Skip to content
Privi Speciality Chemicals logo

Privi Speciality Chemicals

PRIVISCL NSE
₹3,274.70 +3.30 (+0.10%)
P/E
36.60
View as Markdown
MCP
Close 4 Nov 2026 ₹3,274.70 −5.30 −0.16% 1Y
Start ₹3,280.00

Key Fundamentals

MicrocapChemicals & PetrochemicalsChemicals

Price-based figures as of · EPS basis: Consolidated · TTM

ROCE
22.30%
Debt to Equity
0.72
EPS (TTM)
₹89.47
Book Value
₹403.23
Market Cap
—
P/E (TTM)
36.60
P/B
8.12
ROE
26.00%
Dividend Yield
0.15%
EBITDA
₹666 Cr
52W High
₹3,785.30
52W Low
₹2,570.80
Day Range
₹3,222.30 – ₹3,323.90
Volume
1,19,827

Peer Comparison

Commodities › Chemicals › Specialty Chemicals

Privi Speciality Chemicals peer comparison
₹1,510.2058.04₹1,54,107 Cr13.721.42%23.90%31.00%₹15,399 Cr₹2,677 Cr
₹4,613.3083.76₹49,073 Cr6.040.07%7.82%9.64%₹5,303 Cr₹600 Cr
₹8,785.0057.03₹44,060 Cr10.100.09%19.60%21.00%₹3,634 Cr₹789 Cr
₹1,578.4027.48₹20,919 Cr3.320.49%9.82%11.40%₹8,575 Cr₹784 Cr
₹1,540.7086.90₹20,030 Cr7.880.00%9.66%11.90%₹1,231 Cr₹235 Cr
₹447.5530.57₹15,838 Cr2.590.23%7.13%6.86%₹9,010 Cr₹531 Cr
₹5,156.5019.67₹14,827 Cr2.310.59%11.50%14.90%₹6,969 Cr₹788 Cr
₹3,274.7036.60₹12,690 Cr8.120.15%26.00%22.30%₹2,671 Cr₹342 Cr
Median 8 companies₹2,426.5546.82₹20,474 Cr6.960.19%10.66%13.40%₹6,136 Cr₹692 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

52 Average

Data confidence 100/100

Category scores

Quality
68
Strong
Returns, margins, earnings quality 22% weight
Valuation
32
Poor
Cheap vs sector & own history 24% weight
Growth
71
Strong
Sales & profit trajectory 9% weight
Financial Health
49
Average
Solvency, leverage, coverage 9% weight
Momentum
43
Weak
Trend strength, vol-adjusted 12% weight
Ownership
50
Average
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

1
  • Company has delivered good profit growth of 26.8% CAGR over last 5 years

Weaknesses

2
  • Stock is trading at 8.92 times its book value
  • Promoter holding has decreased over last 3 years: -13.4%

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bearish1072
OscillatorsBearish270
Moving AveragesStrong Bearish802

Key readings

RSI (14)
43.17
Neutral
MACD (12,26,9)
−48.78
Bearish
SMA (50)
3,431.39
Bearish
SMA (200)
3,260.82
Bullish

As of

Analyst Rating

Based on 3 analysts
BUY100%

3 of 3 analysts rate Buy, 0 Hold, 0 Sell.

As of

BUY
3
100%
HOLD
0
0%
SELL
0
0%

Growth Rate

From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.

Revenue

Revenue growth by window
5Y+14.96%
3Y+16.83%
1Y+22.04%
TTM+21.62%

Net profit

Net profit growth by window
5Y+22.06%
3Y+147.14%
1Y+71.35%
TTM+62.09%

Operating cash flow

Operating cash flow growth by window
5Y+26.17%
3Y+123.90%
1Y+95.73%
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
5Y+8.95 pp
3Y+13.70 pp
1Y+3.59 pp
TTM+2.68 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹597 Cr
Mar 2018₹1,024 Cr
Mar 2019₹1,341 Cr
Mar 2020₹1,631 Cr
Mar 2021₹1,277 Cr
Mar 2022₹1,404 Cr
Mar 2023₹1,608 Cr
Mar 2024₹1,752 Cr
Mar 2025₹2,101 Cr
Mar 2026₹2,564 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017₹27.00 Cr
Mar 2018₹53.00 Cr
Mar 2019₹94.00 Cr
Mar 2020₹176 Cr
Mar 2021₹117 Cr
Mar 2022₹97.00 Cr
Mar 2023₹21.00 Cr
Mar 2024₹95.00 Cr
Mar 2025₹185 Cr
Mar 2026₹317 Cr

Analyst Forecasts

Forecast For
Dec 26 consensus · EBITDA
₹201 Cr −5.3% vs Sep 26
Reported High Mean Low

AI Analysis — Bull vs Bear

Figures as of 29 Oct 2026
AI opinion · based on fundamentals
Risk medium

Privi Speciality Chemicals Ltd trades at ₹3,296.3 as of 2026-10-29 with a market cap of ₹12,876 cr. The company has demonstrated strong profit growth (TTM profit growth of 61%) and an improving ROE of 22%, but trades at elevated valuations with a P/E of 36.84x and P/B of 9.12x, while promoter holding has declined by 13.4% over three years.

Bull Case 7
  • TTM profit growth of 61% signals a sharp acceleration in earnings, well above the 5-year compounded profit CAGR of 27%
  • ROE of 22% (last year 26%) is well above cost of equity for most Indian chemical companies, indicating efficient capital deployment
  • ROCE of 25.11% reflects strong returns on total capital employed, suggesting pricing power and operational efficiency
  • Compounded sales growth of 22% on a TTM basis indicates healthy top-line momentum alongside profit expansion
  • 5-year compounded profit CAGR of 26.8% demonstrates sustained earnings growth over a meaningful period, not just a single-year spike
  • 3-year stock CAGR of 40% reflects meaningful value creation for shareholders over the medium term
  • Debt-to-equity ratio of 0.72 is manageable for a specialty chemicals company with capex needs, and the high ROCE suggests debt is being deployed productively
Bear Case 8
  • P/E of 36.84x on TTM EPS of ₹89.47 is at a premium to many specialty chemical peers, leaving limited room for execution misses
  • Stock trades at 9.12x book value, well above sector averages, pricing in significant future growth that must be delivered
  • Promoter holding has decreased by 13.4% over the last three years, which may signal reduced insider confidence or dilution-related concerns
  • Dividend yield of just 0.29% offers negligible income cushion, making returns entirely dependent on capital appreciation
  • Stock is trading 12.9% below its 52-week high of ₹3,785.3, indicating recent selling pressure or waning momentum
  • 10-year compounded sales and profit growth data is unavailable, limiting visibility into long-term cyclical performance through full industry downturns
  • Debt-to-equity of 0.72 means the balance sheet carries meaningful leverage; a downturn in chemical demand or margin compression could strain debt servicing
  • 5-year stock CAGR of 14% lags the 3-year CAGR of 40%, suggesting much of the re-rating is recent and may not be sustainable if growth normalizes

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

7d ago

TL;DR: Limited recent news flow for Privi Speciality Chemicals. The only development is a routine NCLT notice for merging two subsidiaries, which is a standard corporate restructuring step with no immediate financial impact. Outlook depends on broader chemical sector trends and upcoming quarterly results.

Neutral 1
  • NCLT merger notice received Oct 6

    Privi Speciality Chemicals received an NCLT notice for amalgamation of two subsidiaries. Member meeting scheduled for October 27, 2026 to approve the scheme.

Quarterly Results

₹ Cr
PRIVISCL quarterly results, ₹ crore
Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales
409
455
404
484
464
533
491
614
559
679
605
722
666
760
Expenses
354
366
314
393
370
423
378
481
427
497
453
541
514
561
Operating Profit
55
89
90
91
94
110
113
133
132
182
151
180
152
200
OPM %
13%
20%
22%
19%
20%
21%
23%
22%
24%
27%
25%
25%
23%
26%
Other Income
6
7
6
8
3
4
2
15
9
0
7
4
15
13
Interest
24
25
24
25
22
22
22
23
24
21
19
18
17
17
Depreciation
31
31
32
30
32
32
32
35
36
36
36
36
37
37
PBT
6
40
39
44
43
61
61
90
81
125
104
130
113
159
Tax %
30%
25%
26%
28%
27%
26%
27%
29%
29%
28%
28%
27%
27%
26%
Net Profit
5
30
29
32
31
45
44
64
58
90
75
94
83
118
EPS (₹)
1.18
7.8
7.36
7.93
8.02
11.42
11.37
17.01
15.84
24.02
19.95
23.96
21.54
—

Sep 2026: from the results filed on 29 Oct 2026, ahead of the full statement, so some rows are blank.

Profit & Loss

₹ Cr
PRIVISCL profit and loss, annual, ₹ crore
Particulars Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
597
1,024
1,341
1,631
1,277
1,404
1,608
1,752
2,101
2,564
2,671
Expenses
525
894
1,128
1,362
1,067
1,209
1,420
1,423
1,643
1,912
2,005
Operating Profit
72
130
213
268
210
195
188
329
458
651
666
OPM %
12%
13%
16%
16%
16%
14%
12%
19%
22%
25%
25%
Other Income
10
16
14
66
43
38
21
26
20.65
19
26
Interest
20
24
29
41
24
25
70
102
92
87
75
Depreciation
27
43
47
63
71
75
108
123
132
144
145
PBT
36
79
152
231
158
133
31
130
255
440
472
Tax %
24%
32%
38%
24%
26%
27%
31%
27%
27%
28%
—
Net Profit
27
53
94
176
117
97
21
95
185
317
342
EPS (₹)
7.21
14.19
24.1
45.1
29.9
24.91
5.68
24.27
47.83
83.77
89.47
Div. Payout %
14%
11%
10%
3%
7%
8%
0%
8%
10%
12%
—

Balance Sheet

₹ Cr
PRIVISCL balance sheet, annual, ₹ crore
Particulars Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
38
38
39
39
39
39
39
39
39
39
Reserves
406
451
537
702
683
773
790
885
1,064
1,373
Borrowings
321
330
491
569
537
933
1,079
1,008
1,143
1,021
Other Liabilities
174
235
359
294
281
431
483
410
544
736
Total Liabilities
939
1,053
1,426
1,604
1,540
2,176
2,391
2,343
2,791
3,170
Fixed Assets
388
437
498
725
598
704
1,017
1,034
1,156
1,169
CWIP
24
49
95
40
175
373
100
99
141
314
Investments
1
3
0
1
0
12
7
40
8
54
Other Assets
527
564
833
839
768
1,087
1,268
1,169
1,485
1,633
Total Assets
939
1,053
1,426
1,604
1,540
2,176
2,391
2,343
2,791
3,170

Cash Flow

₹ Cr
PRIVISCL cash flow, annual, ₹ crore
Particulars Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
17
107
21
247
172
5
49
354
281
550
Investing
80
−81
−139
−206
−242
−321
−133
−180
−294
−358
Financing
−89
−20
122
27
0
333
72
−171
39
−198
Net Cash Flow
7
5
4
68
−69
17
−12
4
26
−6
Free Cash Flow
17
107
46
37
−71
−304
−91
212
−17
230
CFO/EBITDA
49
96
24
120
101
19
33
116
77
102

Ratios

PRIVISCL financial ratios, annual
Particulars Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
106
82
90
60
68
69
67
72
68
75
Inventory Days
236
132
162
135
170
279
311
245
262
235
Days Payable
115
85
95
55
83
138
114
105
134
150
Cash Conversion Cycle
227
129
157
139
155
209
264
212
197
160
Working Capital Days
31
20
40
45
65
19
16
37
35
54
ROCE %
—
13%
18%
20%
12%
10%
6%
12%
16%
22%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Privi Speciality Chemicals insights

64 extracted metrics across FY10–FY27.

Shareholding Pattern

As of Sep 2026

  • Promoters 60.60%
  • Public 17.59%
  • Others 10.07%
  • DIIs 8.96%
  • FIIs 2.78%

No promoter shares pledged as of Sep 2026

Change vs previous quarter

Not shown for some quarters: Others. Not available separately for this quarter: the shareholding filing gives Public and Others as one figure, shown under Public, so Others is left blank rather than estimated.

Documents

Frequently Asked Questions about Privi Speciality Chemicals

What does Privi Speciality Chemicals Ltd do?
Incorporated in 1985, Privi Speciality Chemicals Ltd (Formerly known as Privi Speciality Ltd.) is primarily engaged in the manufacturing, supply and exports of aroma and fragrance chemicals used in soaps, detergents, shampoos, and other fine fragrances.
Where is Privi Speciality Chemicals Ltd (PRIVISCL) listed?
Privi Speciality Chemicals Ltd trades as PRIVISCL on the NSE and under code 530117 on the BSE.
Which sector does Privi Speciality Chemicals Ltd belong to?
Privi Speciality Chemicals Ltd is classified under the Chemicals sector, in the Specialty Chemicals industry.
What is the PE ratio of Privi Speciality Chemicals Ltd?
Privi Speciality Chemicals Ltd trades at a PE ratio of 36.60 as of 4 Nov 2026, on earnings per share of ₹89.47, against a book value of ₹403.23 per share.
What is the 52-week high and low of Privi Speciality Chemicals Ltd?
Over the last 52 weeks Privi Speciality Chemicals Ltd has traded between ₹2,570.8 and ₹3,785.3 as of 4 Nov 2026.
Does Privi Speciality Chemicals Ltd pay dividends?
Privi Speciality Chemicals Ltd has a dividend yield of 0.15%.
What is the Return on Equity (ROE) of Privi Speciality Chemicals Ltd?
Privi Speciality Chemicals Ltd reported a return on equity of 26.00%. Its debt-to-equity ratio is 0.72.

Company Information

Incorporated in 1985, Privi Speciality Chemicals Ltd (Formerly known as Privi Speciality Ltd.) is primarily engaged in the manufacturing, supply and exports of aroma and fragrance chemicals used in soaps, detergents, shampoos, and other fine fragrances.

Website privi.com
CEO Mr. Mahesh Purshottambhai Babani
Employees 672
Listed 8 May 2015
Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/PRIVISCL.md for Privi Speciality Chemicals Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More